Crossref
Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study
Research in Oncology · 2007
DOI: 10.21608/resoncol.2007.372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Oncology, 2007. Verfasst von E zzat Safwat.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Safwat, E. Z. (2007). Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study. Research in Oncology. https://doi.org/10.21608/resoncol.2007.372
Vancouver
Safwat EZ. Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study. Research in Oncology. 2007. doi:10.21608/resoncol.2007.372
BibTeX
@article{Safwat2007,
author = {Safwat, E zzat},
title = {Single agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study},
journal = {Research in Oncology},
year = {2007},
doi = {10.21608/resoncol.2007.372}
}
EUVIMED